FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend

Sep.20.2024
FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend
FUMOT, a leading e-cigarette brand in Germany, shares market insights at InterTabac amid strict regulations and growing competition.

On September 19th, 2024, the InterTabac tobacco exhibition in Dortmund, Germany officially opened. On the opening day, 2Firsts conducted an exclusive interview with the popular e-cigarette brand FUMOT.

FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend
FUMOT's best-selling product in Germany | Image source: 2Firsts

 

FUMOT staff briefed 2Firsts on the current situation in the German market. According to their information, leading brands in the compliant German market include ELFBAR, BLU, HQD, and FLERBAR. Additionally, FUMOT's flagship products have achieved shipments of several million units in the German market, making it their key market.

 

FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend
FUMOT's new "2+10" products | Image source: 2Firsts

 

When discussing the mainstream product types in the German market, the staff member stated that due to factors such as low cost-effectiveness, small-sized disposable products have seen a significant decrease in market share in Germany, becoming increasingly marginalized. Conversely, new large-sized disposable products that comply with TPD standards are emerging, such as innovative products like "n in 1" and "2+10." Therefore, at this trade show, FUMOT also introduced a variety of innovative products like "2+10" to meet the demands of the German market and solidify its market position.

 

For brands looking to enter the German market, the staff member believes that although Germany is an important market in Europe with promising prospects, the acceptance of new brands is relatively low. Distributors tend to prefer familiar brands. Therefore, achieving success in the German market requires long-term cultivation and careful planning.

 

When it comes to regulation, the above-mentioned staff shared the regulatory situation of the e-cigarette market in Germany. According to their information, Germany imposes high taxes on e-liquid products, with a tax of 2 euros per compliant 10ml e-liquid. German police also conduct strict inspections of tax labels attached to products at the retail end. Among them, Berlin has the highest inspection frequency in the market, but the penalties for violations are relatively light, usually limited to confiscation of goods or fines. In contrast, the market in Cologne has the strictest regulation, and sellers of tax evasion products may face criminal liability.

 

According to reports, despite this, there are still underground markets in Germany, but these markets mainly operate through online channels such as WhatsApp and Instagram. Due to the high risks involved in offline transactions, only a few retail stores dare to get involved, and they usually only sell to trusted customers.

 

In the interview, FUMOT's onsite staff repeatedly mentioned the keyword "compliance." They believe that with the increasing strictness of market supervision in Germany, brands must actively align with compliance standards in order to achieve long-term stable development.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07